Table of Contents
Table 5-59: Orange
Table 5-61: Parke
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 66 | 582.3 | 308 | 567.7 | 30 | 292.7 | 152 | 296.6 |
| Esophagus | * | # | 8 | 14.9** | * | # | 7 | 14.0** |
| Stomach | * | # | 4 | # | * | # | 3 | # |
| Colon excluding Rectum | * | # | 12 | 24.9** | * | # | 11 | 25.5** |
| Rectum and Rectosigmoid Junction | * | # | 7 | 12.4** | * | # | 1 | # |
| Liver | * | # | 1 | # | * | # | 1 | # |
| Pancreas | * | # | 8 | 14.3** | * | # | 7 | 12.8** |
| Lung and Bronchus | 11 | 102.2** | 76 | 138.2 | 14 | 131.3** | 63 | 119.6 |
| Melanoma of the Skin | * | # | 9 | 14.5** | * | # | 4 | # |
| Prostate | 12 | 98.1** | 66 | 122.4 | * | # | 9 | 18.2** |
| Urinary Bladder | 10 | 90.1** | 29 | 54.8 | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 13 | 23.0** | * | # | 6 | 10.9** |
| Brain and Other Nervous System | * | # | 6 | 11.2** | * | # | 4 | # |
| Non-Hodgkin Lymphoma | 6 | 57.9** | 14 | 25.7** | * | # | 7 | 13.8** |
| Myeloma | * | # | 2 | # | * | # | 2 | # |
| Leukemia | * | # | 11 | 19.8** | * | # | 3 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2004 | 2000 - 2004 | 2004 | 2000 - 2004 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 64 | 501.7 | 284 | 464.6 | 30 | 233.5 | 124 | 200.7 |
| Colon excluding Rectum | 6 | 46.8** | 27 | 43.1 | * | # | 15 | 24.0** |
| Rectum and Rectosigmoid Junction | * | # | 8 | 13.5** | * | # | 1 | # |
| Liver | * | # | 0 | # | * | # | 1 | # |
| Pancreas | * | # | 9 | 15.4** | * | # | 9 | 15.4** |
| Lung and Bronchus | 11 | 84.2** | 50 | 81.1 | 11 | 84.4** | 41 | 66.9 |
| Melanoma of the Skin | * | # | 9 | 15.1** | * | # | 1 | # |
| Breast | 15 | 119.6** | 70 | 113.2 | * | # | 11 | 18.0** |
| Cervix Uteri | * | # | 5 | 8.4** | * | # | 0 | # |
| Corpus Uteri | 8 | 63.9** | 18 | 29.8** | * | # | 2 | # |
| Ovary | * | # | 8 | 13.1** | * | # | 7 | 10.8** |
| Urinary Bladder | * | # | 4 | # | * | # | 2 | # |
| Kidney and Renal Pelvis | * | # | 6 | 9.3** | * | # | 1 | # |
| Brain and Other Nervous System | * | # | 3 | # | * | # | 2 | # |
| Non-Hodgkin Lymphoma | * | # | 13 | 21.1** | * | # | 2 | # |
| Myeloma | * | # | 3 | # | * | # | 7 | 11.5** |
| Leukemia | * | # | 6 | 9.6** | * | # | 4 | # |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, June 2007
Table of Contents
Table 5-59: Orange
Table 5-61: Parke
